Abstract Background Immune protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies by prior infection and vaccination history. This study evaluated whether 2 coronavirus disease (COVID-19) vaccine doses after prior infection provide additional protection compared with a single dose. Metho...
H. Chemaitelly, H. Ayoub, Peter V. Coyle et al.· Open Forum Infectious Diseas...· 0 citations
Background Autoimmune disorders have been linked to increased cardiovascular disease (CVD) risk, but it is unclear whether the association is uniform across conditions or is concentrated in specific diseases, and whether inflammatory markers add value in a Middle Eastern primary-care setting. We examined disease-specif...
Aisha Al-Khinji, D. Malouche, A. Al-Hor et al.· American Heart Journal Plus:...· 1 citation
Abstract Background Observational studies are central to assessing vaccine effectiveness and informing public health policy. The two most common designs are test-negative case-control and cohort studies, yet direct comparisons of their performance using the same population, data sources, and analytic strategies remain...
Layan Sukik, Pradipta Paul, H. Ayoub et al.· International Journal of Epi...· 0 citations
The findings highlight the need to strengthen surveillance, improve data integration, and sustain vaccination efforts in line with the World Health Organization Defeating Meningitis by 2030 roadmap.
Hissa Al-Kuwari, Aisha Thani Al-Kuwari, A. Bakri et al.· Qatar medical journal· 0 citations
It is shown that vaccine effectiveness against infection and severe, critical, or fatal COVID-19 remained consistent across matching strategies, despite differences in non-COVID-19 mortality, highlighting the importance of using specific outcomes in vaccine effectiveness studies.
H. Chemaitelly, H. Ayoub, Peter V. Coyle et al.· Communications Health· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
